Zhao Beiqun, Hollandsworth Hannah M, Lopez Nicole E, Parry Lisa A, Abbadessa Benjamin, Cosman Bard C, Ramamoorthy Sonia L, Eisenstein Samuel
Department of Surgery, University of California, San Diego, California, USA.
Department of Surgery, VA San Diego Healthcare System, San Diego, California, USA.
ANZ J Surg. 2020 Dec;90(12):E154-E162. doi: 10.1111/ans.16221. Epub 2020 Aug 17.
The rectum is a common site for neuroendocrine tumours of the gastrointestinal tract. Diagnosis of these tumours has been increasing in recent years, highlighting the need to better define treatment options for patients with rectal neuroendocrine tumours (rNETs).
We performed a retrospective analysis using the National Cancer Database (2004-2014) to compare overall survival (OS) between local excision (LE) and radical resection (RR). To minimize bias, we performed three propensity score-matched comparisons stratified by tumour size: <10 mm, 10-20 mm, >20 mm. We compared OS by Kaplan-Meier analysis. We also examined margin status and postoperative outcomes for each comparison.
A total of 12 996 patients underwent surgical treatment for rNET. There was no significant difference in probability of 10-year OS between LE and RR for patients with tumours <10 mm (88.6% versus 83.8%, P = 0.631, respectively) and tumours 10-20 mm (69.5% versus 69.3%, P = 0.226, respectively). In patients with tumours >20 mm, probability of 10-year OS was significantly longer in the LE group (76.5% versus 37.0%, P < 0.001). For all tumour sizes <10 mm and >20 mm, RR had significantly higher rates of 30-day readmission and negative margins. In subset analysis, there was no difference in OS for patients with positive margins after LE versus negative margins after RR for all tumour size groups.
Our findings suggest that LE is a reasonable treatment option in patients with rNETs, especially for patients with high perioperative risk. Limitations to this study include its retrospective nature and inability to analyse surgeon decision-making.
直肠是胃肠道神经内分泌肿瘤的常见发病部位。近年来,这些肿瘤的诊断率不断上升,凸显了更好地为直肠神经内分泌肿瘤(rNETs)患者确定治疗方案的必要性。
我们使用国家癌症数据库(2004 - 2014年)进行了一项回顾性分析,以比较局部切除(LE)和根治性切除(RR)之间的总生存期(OS)。为尽量减少偏差,我们按肿瘤大小进行了三次倾向评分匹配比较:<10毫米、10 - 20毫米、>20毫米。我们通过Kaplan-Meier分析比较了总生存期。我们还检查了每次比较的切缘状态和术后结果。
共有12996例患者接受了rNET的手术治疗。对于肿瘤<10毫米的患者,LE组和RR组的10年总生存率无显著差异(分别为88.6%和83.8%,P = 0.631);对于肿瘤10 - 20毫米的患者,两组的10年总生存率也无显著差异(分别为69.5%和69.3%,P = 0.226)。对于肿瘤>20毫米的患者,LE组的10年总生存率显著更长(76.5%对37.0%,P < 0.001)。对于所有<10毫米和>20毫米的肿瘤大小,RR组的30天再入院率和切缘阴性率显著更高。在亚组分析中,对于所有肿瘤大小组,LE术后切缘阳性患者与RR术后切缘阴性患者的总生存期无差异。
我们的研究结果表明,LE是rNETs患者的一种合理治疗选择,尤其是对于围手术期风险高的患者。本研究的局限性包括其回顾性性质以及无法分析外科医生的决策过程。